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Background: Necrotizing enterocolitis (NEC) is a devastating intestinal disease that afflicts 10% of extremely
preterm infants. The contribution of early intestinal colonization to NEC onset is not understood, and predictive
biomarkers to guide prevention are lacking. We analyzed banked stool and urine samples collected prior to disease
onset from infants <29 weeks gestational age, including 11 infants who developed NEC and 21 matched controls
who survived free of NEC. Stool bacterial communities were profiled by 16S rRNA gene sequencing. Urinary
metabolomic profiles were assessed by NMR.
Results: During postnatal days 4 to 9, samples from infants who later developed NEC tended towards lower alpha
diversity (Chao1 index, P = 0.086) and lacked Propionibacterium (P = 0.009) compared to controls. Furthermore, NEC
was preceded by distinct forms of dysbiosis. During days 4 to 9, samples from four NEC cases were dominated by
members of the Firmicutes (median relative abundance >99% versus <17% in the remaining NEC and controls,
P < 0.001). During postnatal days 10 to 16, samples from the remaining NEC cases were dominated by Proteobacteria,
specifically Enterobacteriaceae (median relative abundance >99% versus 38% in the other NEC cases and 84% in
controls, P = 0.01). NEC preceded by Firmicutes dysbiosis occurred earlier (onset, days 7 to 21) than NEC preceded by
Proteobacteria dysbiosis (onset, days 19 to 39). All NEC cases lacked Propionibacterium and were preceded by either
Firmicutes (≥98% relative abundance, days 4 to 9) or Proteobacteria (≥90% relative abundance, days 10 to 16)
dysbiosis, while only 25% of controls had this phenotype (predictive value 88%, P = 0.001). Analysis of days 4 to 9 urine
samples found no metabolites associated with all NEC cases, but alanine was positively associated with NEC cases that
were preceded by Firmicutes dysbiosis (P < 0.001) and histidine was inversely associated with NEC cases preceded by
Proteobacteria dysbiosis (P = 0.013). A high urinary alanine:histidine ratio was associated with microbial characteristics
(P < 0.001) and provided good prediction of overall NEC (predictive value 78%, P = 0.007).
Conclusions: Early dysbiosis is strongly involved in the pathobiology of NEC. These striking findings require validation
in larger studies but indicate that early microbial and metabolomic signatures may provide highly predictive
biomarkers of NEC.
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Preterm birth contributes disproportionately to the global
burden of morbidity and mortality in infancy. Necrotizing
enterocolitis (NEC) is a devastating emergency of preterm
infants, which affects about 10% of infants born <29 weeks
gestational age, with a case-fatality of about 30% [1,2].
NEC typically occurs without clinical warning between 3
days and several months of postnatal life [3]. Risk factors
for NEC include immaturity [4], timing and type of infant
feeding [5,6], extended empirical use of antibiotics [7,8],
and intestinal bacterial colonization [9-12]. Unfortunately,
after decades of research, the specific pathogenesis of
NEC remains an enigma, and validated biomarkers to
identify individuals at highest risk of disease are lacking.
Intestinal colonization has remained an important target
of investigation in the etiology of NEC. The microbial
community of preterm infants, compared to healthy, term
infants, consists of dramatically fewer beneficial species,
lower bacterial diversity, and more pathogens [9-12]. NEC
does not occur in germ-free animals, lending credence to
the importance of intestinal colonization to the develop-
ment of NEC [13]. Several epidemiologic studies in pre-
term infants report an association between early empirical
antibiotic use and subsequently increased risk of NEC,
while randomized, controlled trials in preterm infants sug-
gest that probiotic agents may reduce the risk of NEC
[7,8,14]. The immature enterocytes of preterm infants ex-
hibit excessive signaling in the TLR4 pathway in response
to the lipopolysaccharide (LPS) presented by Gram-
negative bacteria, and this interaction has often been im-
plicated in NEC onset [12,13,15]. Various other agents
have also been associated with NEC onset, including bac-
terial, viral, and fungal pathogens [9-11,16-18]. Despite
this, no specific microbial pattern has been consistently
identified with NEC onset.
Early colonizing organisms interact with the intestinal
mucosa to shape the developing immune system towards
homeostasis or dysregulation [19-24], and could thus
contribute to the pathobiology leading to onset of NEC.
However, early colonization has been largely overlooked as
a focus of study. To address this gap, we examined the
early microbial community to identify predictive microbial
biomarkers of later NEC in a prospective study of preterm
infants. Culture-independent 16S rRNA gene sequencing
of stool samples from 4 to 16 days of life was utilized to
identify microbial community signatures. Because intes-
tinal bacteria can influence the metabolic profiles of their
hosts [25-29], we pursued urinary metabolomics to identify
surrogate biomarkers of NEC.
Methods
Preterm infant cohort
All infants in this study were part of an ongoing larger
study of the preterm microbiome and determinants ofNEC, which was conducted in two level III neonatal inten-
sive care units (NICUs) in Cincinnati, Ohio. Infants
were enrolled between October 2009 and August
2010. Enrollment criteria included being free of congenital
anomalies and survival free of NEC in the first week of
postnatal life. After Institutional Review Board approval
and parental informed consent, standardized clinical data
were collected following the National Institute of Child
Health and Human Development (NICHD) Neonatal
Research Network protocol until discharge from hospital.
All cases were reviewed by a senior neonatologist (KRS).
A total of 35 preterm infants <29 weeks gestational
age and <1,200 g birth weight were included in this study.
The primary analysis included 11 infants who developed
NEC and 21 control infants. As a secondary comparator,
we included three non-NEC deaths attributed to respiratory
distress syndrome or suspected infection. Non-NEC deaths
were included as they represent a competing outcome with
NEC during hospitalization in the NICU, and clinical stud-
ies of probiotics and antibiotics report similar associations
with NEC and death [7,8,14], suggesting the possibility that
they may be similarly related to the intestinal microbiome.
Controls were consecutively enrolled infants from the same
NICUs who survived free of NEC or sepsis. NEC was
defined as modified Bell’s stage II or III [30].
The infant microbiome was analyzed by postnatal time
periods, days 4 to 9 and 10 to 16. These periods were
selected because the extremely premature infants in this
study did not stool consistently and did not stool prior to
day 4 of life. Each period included two planned sample col-
lections, increasing the chances of having a sample available
from each infant during the interval. Stools were collected
from soiled diapers; urine samples were collected from the
infant diaper using cotton balls. Upon collection, samples
were immediately refrigerated in the NICU and transported
to the study laboratory daily. Stool was scraped into a tube
containing thioglycollate, and frozen at −80°C until the
DNA could be extracted. Upon removal from the cotton
ball, urine samples were frozen at −80°C without an addi-
tive until metabolomic analysis was performed. All sample
collection and storage utilized preprinted, bar-coded labels.
In the few instances when two stool samples were
available per infant in a collection period, statistical
independence was ensured by including only the earlier
sample. Further, only samples collected prior to diagnosis
of NEC were included. These criteria resulted in inclusion
of 58 stool samples for analysis, 18 from the 11 NEC
cases, 37 from the 21 control infants, and 3 from the 3
non-NEC deaths. Urine samples were collected during
days 4 to 9, and all available samples collected prior to
NEC onset in that time period were analyzed by NMR
[31]. A total of 60 urine samples, 18 from 11 NEC cases,
36 from 20 controls, and 6 from non-NEC deaths, were
included in initial analyses. Final analysis of urinary
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in the day 4 to 9 period.
DNA extraction
Bacterial DNA was extracted from infant stool samples
using one of two methods: phenol-chloroform or the
QiaAmp DNA stool kit (Qiagen Sciences, Germantown,
MD). For the phenol-chloroform method, samples were
thawed, centrifuged and supernatant removed. From the
sample, 0.2 g of stool was transferred to a 2 mL screw-cap
tube containing 0.3 g of 1 mm zirconia beads. Next, 1 mL
Tris-EDTA (TE) buffer was added and the sample
resuspended. Then, 150 μL of buffer saturated phenol was
added and the sample bead beat for 3 minutes at 4°C. The
sample was then allowed to sit for 1 minute at 4°C before
extraction with 150 μL chloroform:isoamyl alcohol (24:1).
Samples were centrifuged for 5 minutes at 15,700g at 4°C
and the resulting aqueous layer was transferred to a clean
tube and again extracted with an additional 150 μL phenol
and 150 μL chloroform:isoamyl alcohol. Samples were then
centrifuged for 2 minutes at 15,700g at 4°C. The aqueous
layer was subjected to two additional chloroform:isoamyl
alcohol extractions. The resulting aqueous layer was trans-
ferred to a clean microfuge tube a final time and 4 μL of
5 mg/mL glycogen was added and mixed. This was
followed by the addition of 1/10 volume of 3 molar sodium
acetate and 2 volumes of 70% cold (−20°C) ethanol. The
samples were mixed and then centrifuged at 15,700 g for 5
minutes at 4°C. The supernatant was discarded and
the pellet resuspended in 100 μL TE buffer. For the
extractions using the QiaAmp DNA stool kit, samples
were thawed and 0.2 g of stool was transferred to a
bead beating tube containing 0.3 g of 0.1 mm glass
beads, 1.4 mL of buffer ASL was added, and bead
beating was conducted for 3 minutes on the homogenize
setting. The suspension was then heated at 70°C for 5 mi-
nutes, and the manufacturer’s instructions followed.
16S rRNA gene analysis
The V3 to V5 window of the 16S rRNA gene was amplified
and sequenced using 454 FLX Titanium sequencing as
already described in full detail [32]. A total of 1.3 million
resulting sequences were processed using a data curation
pipeline implemented in mothur [33], complemented by
UCHIME for chimera detection [34]. This processing has
been detailed previously [35], with the modification that
AbundantOTU was replaced by Newbler for assembly-
based error reduction [36] and followed by mothur's
implementation for operational taxonomic unit (OTU)
clustering (parameters: method = average, cutoff = 0.03,
precision = 1,000). The mean read count per sample was
4,989. Representative sequences per OTU were classified
with the MSU RDP classifier v2.2 [37] using the
Greengenes taxonomy [38]. The 16S rRNA gene sequencesobtained from the study samples were assigned to a total of
411 distinct OTUs. OTUs were then assigned phylogenetic
classifications, typically to the genus level.
Metabolomic analysis
Urine samples were thawed on ice immediately prior to
preparation for NMR analysis. A 1 mL aliquot of each sam-
ple was centrifuged for 10 minutes at 2,655 g, 350 µL of
clarified urine pipetted into a 1.5 mL microcentrifuge tube,
and 350 µL of buffer added to each sample. Next 600 µL of
the urine/buffer mixture was pipetted into a 5-mm NMR
tube. All NMR experiments were carried out on a Bruker
Avance™ III spectrometer operating at 600 MHz 1H
frequency equipped with a room-temperature 5-mm
triple-resonance probe with inverse detection and
controlled by TopSpin 3.0 (Bruker Biospin, Germany).
Experiments were conducted at 298 K. Data were collected
using a spectral width of 20.0 ppm. Three 1H NMR experi-
ments, optimized by Bruker (Bruker BioSpin, Germany) for
use in metabonomic studies, were run on all samples: a
standard one-dimensional (1D) presaturation (zgpr), a 1D
first increment of a NOESY (noesygppr1d), and a CPMG
(cpmgpr1d); however, only the CPMG, which produced
superior baselines for analysis, was used for metabolomic
analysis. The transmitter offset frequency (O1) was adjusted
to obtain optimal water suppression. The 90° pulse widths,
determined for every sample using the automatic pulse
calculation feature in TopSpin, were between 10 and 12 μs.
Water suppression in all experiments was achieved by
irradiation of the water peak during the recycle delay. Next
1D zgpr 1H NMR spectra were collected to assess the shim
quality, which was considered acceptable when the line
width was <1 Hz and the line shape enabled detection of
resolved C13 satellites for the TSP internal standard. The
CPMG experiment used 64 transients with 4 dummy scans,
46,280 points per spectrum giving an acquisition time of
1.87 s, a T2 filter loop of 128 with an echo time of 1 ms,
apodized using −0.01 Hz of exponential line broaden-
ing, and a 4-s recycle delay. All NMR spectra were
phased, baseline corrected, and subjected to chemical
shift registration relative to TSP in TopSpin 3.0
(Bruker BioSpin, Germany).
Statistical methods
Differences in clinical characteristics of cases and controls
were tested using Fisher’s exact test for categorical variables
and analysis of variance, t-tests or Kruskal–Wallis for con-
tinuous variables, as appropriate. The Kruskal–Wallis test
was used to compare the relative abundance of distinct
taxonomic units. Data were analyzed using R [39], linear
discriminant analysis effect size (LEfSe) [40], QIIME
[41,42], and SAS [43]. LEfSe was used to identify the phylo-
genetic features that differed significantly between all NEC
cases and controls and later between NEC sub-types and
Table 1 Characteristics of study infants
Variable, description NEC Controls
n = 11 n = 21
Birth weight, mean (SD) (g) 791 (212) 839 (187)
Gestational age, mean (SD) (weeks) 25.5 (1.8) 25.9 (1.5)
Non-Hispanic black, number (%) 5 (45.5) 8 (38.1)
Male, number (%) 6 (54.6) 8 (38.1)
Patent ductus arteriosus (PDA), number (%) 7 (63.36) 12 (57.1)
Primiparous, number (%) 7 (63.6)a 5 (23.8)
Prenatal steroids given (any), number (%) 10 (90.9) 19 (90.5)
Hypertension/eclampsia, number (%) 2 (18.2) 7 (33.3)
Antepartum hemorrhage, number (%) 1 (9.1) 5 (23.8)
Multiple births, number (%) 1 (9.1) 7 (33.3)
Antepartum antibiotic therapy, number (%) 6 (54.6) 10 (47.6)
Cesarean section delivery, number (%) 7 (63.6) 14 (66.7)
Chorioamnionitis, number (%) 1 (9.1) 1 (4.8)
Antibiotic use in the first week for
≥5 d, number (%)
4 (36.4) 6 (28.6)
aNEC vs controls, primiparity P = 0.05.
NEC: necrotizing enterocolitis.
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differences in abundance between groups at the alpha level
of 0.05 [40].
Microbial community analysis
We first examined alpha diversity [44,45], which was ana-
lyzed using the Simpson diversity index and Chao1 richness
index. Samples collected prior to NEC onset were
compared to controls without elimination of rare
reads but after rarefying (standardizing) to 2,000 sequence
reads per sample.
To examine the beta diversity of microbial communities,
we used non-metric dimensional scaling (NMDS) [46,47],
undertaken in R, to ordinate the microbial communities of
samples based on the weighted UniFrac distance calculated
by QIIME. To improve signal to noise and reduce random
error, we excluded rare OTUs from the beta diversity ana-
lyses. Rare OTUs were defined as those detected in only
one sample or with less than five sequences in the overall
dataset [10]. This resulted in 99 distinct OTUs that were
included for analysis.
Ordination using NMDS was undertaken with several
random starts to avoid entrapment in local optima. The
results were centered and scaled, so that the variance
was maximized along the first NMDS axis. This method of
ordination was chosen because NMDS measures the close-
ness of fit (stress) based on ranking of the dissimilarity of
values, with no assumption of multivariate normality, and
is a powerful and flexible method that handles sparse, non-
parametric data well. Use of the weighted UniFrac distance
metric was selected, as it accounts for the relative abun-
dance and relatedness of taxa, rather than merely their
presence or absence. Selection criteria for the number of
dimensions in NMDS analysis were based on the protocol
used in PC-ORD 6 software [47]. For each ordination, we
then ran a cluster analysis on the UniFrac distance matrix
using the Ward minimum variance method [48] to object-
ively identify clusters of samples with similar microbial
composition. In this method, the distance between two
clusters is the analysis of variance sum of squares between
the clusters summed over all the variables. At each step,
the within-cluster sum of squares is minimized over all
partitions obtainable by merging clusters from the previous
generation in order to maximize the likelihood at each level
of the hierarchy. The number of clusters is determined by
examining the scree plot resulting from the pseudo F and T
plots. We used the SAS PROC Cluster procedure to
conduct the clustering analysis.
Metabolomics allows identification of distinct patterns
of small molecules generated during both host and micro-
bial cellular metabolism [25-29]. Urinary metabolomics
was thus undertaken in search of surrogate biomarkers of
dysbiosis and additional clues regarding the microbially
distinct NEC cases in relation to controls and to eachother. Urinary metabolite data were analyzed using princi-
pal component analysis (PCA) as implemented in AMIX
(Bruker Biospin, Billerica, MA). NMR spectra were pre-
pared for PCA using manual binning to avoid splitting of
peaks. Individual metabolites were compared between NEC
cases and controls using a t-test as implemented by Proc
MULTTEST in the SAS 9.2 software (SAS Institute, Cary,
NC). The Benjamini and Hochberg procedure [49] was
used to control for multiple comparisons, using an adjusted
P value of <0.05 [49]. After identification of significant
metabolites, generalized estimating equations were applied
to adjust for multiple samples per subject and to control
for potential confounding factors. Only metabolites that
were significant at <0.05 in both analyses were considered
significant. A total of eight samples analyzed by NMR were
excluded based on poor sample quality or as outliers based
on the Hotelling T2 method [50].
Results
Preterm infant cohort
The characteristics of NEC cases versus controls are shown
in Table 1. Controls were generally well matched to NEC
cases on clinical factors, and did not differ in regard to birth
weight (median 850 g), gestational age (median 26 weeks),
race (37% black), gender (51% female), mode of delivery
(66% Cesarean section), maternal antibiotic use at the time
of delivery (51%), or infant antibiotic use for ≥5 days in the
first week (34%). All study infants were fed the mother’s
own milk or human donor milk; the timing and degree of
feeding was not significant in relation to NEC. Only
primiparity differed between NEC cases (64%) and controls
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microbial composition. Of the 11 NEC cases, 8 were Bell’s
stage II and 3 were Bell’s stage III (surgically treated). Four
of the NEC cases died, and three of the NEC cases devel-
oped sepsis (two Klebsiella isolates, one coagulase-negative
Staphylococcus isolate). The three non-NEC deaths inclu-
ded for comparison were white, male, and younger (24 and
25 weeks gestational age) and smaller (<850 g birth weight)
than the other infants, but otherwise unremarkable. For ac-
cess to the metadata, please see Additional file 1.
Dominant organisms
Consistent with previous studies in preterm infants
[12,51-53], the dominant phyla were Proteobacteria and
Firmicutes, with a minor contribution (1% to 2%) from
Bacteroidetes and Actinobacteria. The most common
genera were, in order of relative abundance: Enterobacter,
Staphylococcus, Escherichia, Enterococcus, Leuconostoc,
Lactococcus, Streptococcus, and Clostridia. The first four
genera accounted for more than 90% of the microbial
sequence reads. Pseudomonas, another Proteobacteria often
associated with NEC or sepsis in preterm infants, occurred
in 31% of samples, while together Lactobacillaceae and
Bifidobacteriaceae, beneficial Gram-positive organisms (of
the phyla Firmicutes and Actinobacteria, respectively), were
present in only 19% of samples.
At the level of phyla, controls had a median relative
abundance of approximately 80% Proteobacteria (Gram-
negative organisms) and 20% Firmicutes (Gram-positive or-
ganisms), with a small proportion of Bacteroidetes and
Actinobacteria; this pattern was remarkably stable over the
first few weeks of life. Furthermore, most of the sequences
contributing to the relative abundance of these large phyla
came from only a few host-associated genera, Enterococcus
and Staphylococcus for Firmicutes and Enterobacter and
Escherichia for Proteobacteria. In infants who later
developed NEC, microbial community composition differed
sharply with the median relative abundance of Proteo-
bacteria less than 40% and Firmicutes approximately 60%
during postnatal days 4 to 9. A dramatic difference was
then observed in samples from NEC cases such that over
90% of the microbial communities were composed of
Proteobacteria, while less than 10% were composed of
Firmicutes (Figure 1). In the three non-NEC deaths (data
not shown), Firmicutes strongly dominated, accounting for
70% to 90% of microbial communities, with most of the
remaining community composition being Proteobacteria.
Systematic comparison of all NEC samples and all
control samples collected between postnatal days 4 to 16
found no significant differences in microbial compos-
ition. NEC and control samples were then compared by
week, and the only significant difference occurred in the
relative abundance of Propionibacterium, a genus of the
phylum Actinobacteria. Propionibacterium includes bothskin- and intestinal-tract-colonizing organisms; members
have demonstrated probiotic as well as pathogenic potential
[54,55]. During days 4 to 9, Propionibacterium was identi-
fied in samples from 10 (56%) of the 18 control infants, but
none of the 9 infants who later developed NEC (P = 0.01,
Figure 2A). No difference was found in the relative abun-
dance of Propionibacterium between NEC and control
samples collected from days 10 to 16 of life.
Alpha diversity
During postnatal days 4 to 9, infants who later devel-
oped NEC tended to have samples with lower alpha
diversity than controls as measured by the Chao1
index (median 9.2 for NEC, 18.4 for control samples;
Kruskal–Wallis, P = 0.086; Figure 2B) with a similar trend
using the Simpson index (P = 0.221, data not shown).
After day 9 of life, NEC samples continued to trend
towards lower median alpha diversity than controls, but
no significant differences were found by either index.
Dysbiosis-identified sub-types of NEC
For all study infants, the relative similarity of microbial
communities between samples (beta diversity) was then
examined by calculating their weighted UniFrac distances,
and visualized using non-metric multi-dimensional scaling
ordination (NMDS). Based on ordination of day 4 to 9
samples (Figure 3A), application of the Ward minimum
variance identified four clusters, designated I though IV,
indicating microbial community similarity. Of these, only
Clusters I and II included NEC cases. Cluster I consisted of
samples from four NEC cases (NEC-I), two non-NEC
deaths, and two controls (Figure 3B), and was characterized
by dominance of organisms of the phylum Firmicutes, class
Bacilli. Cluster II samples consisted of the remaining 5
NEC cases (NEC-II) as well as 12 of the 18 controls, and
were characterized by dominance of organisms of the
phylum Proteobacteria, family Enterobacteriaceae.
Within Cluster I, the genera Enterococcus and Staphylo-
coccus, taxa representing different orders of Bacilli,
accounted for 98% or more of the microbial community
of samples from NEC-I infants. In the two non-NEC
deaths found in Cluster I, the same taxa constituted 80%
and 95% of their microbial communities, and in the two
control samples, 62% and 73%. Comparing the NEC cases
between clusters, the relative abundance of Firmicutes
(specifically, Bacilli) was significantly higher in samples
from NEC-I than NEC-II cases (median 99.3%, NEC-I ver-
sus 17%, NEC-II, P = 0.014). Further, NEC-I samples had
a significantly greater relative abundance of Firmicutes,
specifically, Bacilli (P = 0.001), compared to all controls.
Conversely, the relative abundance of Proteobacteria, fam-
ily Enterobacteriaceae, was significantly higher in samples
from NEC-II than NEC-I cases (median 83%, NEC-II
versus 0.4%, NEC-I, P = 0.014), but NEC-II samples did
Figure 1 The relative abundance of bacterial phyla in infants who developed NEC vs control infants. Columns represent samples from
days of life for 4 to 9 and 10 to 16. Data are graphed as box plots. The middle bar represents the median, the outer horizontal lines of the box
represent the 25th and 75th percentiles. Dots above or below each box indicate outliers. NEC: necrotizing enterocolitis.
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to all controls during days 4 to 9.
The ordination of samples from days 10 to 16 (Figure 4A)
and application of the Ward minimum variance method
identified three microbial community clusters (A, B and D)
and an outlier (C). The NEC-I infants that had tightly
clustered in samples from the first 4 to 9 days were
dispersed across Clusters A, B and D in this ordination,
with no discernible similarity. In contrast, consistent withFigure 2 Microbial community differences between NEC and control
abundance of the genus Propionibacterium in 18 control samples and 9 sam
who later developed NEC, but 10 (56%) of the control samples had detecta
presence or absence in NEC vs control samples, P = 0.009). (B) This box plo
life. NEC cases tended towards lower diversity than controls, but the comp
the middle bar represents the median, the outer horizontal lines of the bo
plots indicate the values of individual samples. Dots are distributed horizonthe ordination for days 4 to 9, all of the NEC-II cases were
found in a single cluster (Cluster A) during days 10 to 16.
Cluster A also included one of the dispersed NEC-I cases,
the composition of which was 83% Enterobacter. Cluster A
thus included 7 (78%) of the 9 NEC cases and 12 (63%) of
19 controls, and was characterized by preponderance of
Proteobacteria, specifically, the family Enterobacteriaceae
(Figure 4B). Compared to all control samples during days
10 to 16, the six NEC-II/Cluster A cases had a significantlyinfants, days 4 to 9 samples. (A) This box plot indicates the relative
ples prior to NEC onset during days 4 to 9 of life. None of the infants
ble amounts of Propionibacterium (using Fisher’s exact test for the
t indicates the Chao1 richness index in samples from days 4 to 9 of
arison was not significant (Kruskal–Wallis, P = 0.086). For each box plot,
x represent the 25th and 75th percentiles. The dots overlaying the
tally in order to prevent overlapping. NEC: necrotizing enterocolitis.
Figure 3 NMDS ordination of microbial communities for days 4 to 9 of life. (A) This ordination was based on weighted UniFrac beta
diversity and run with three dimensions in the vegan package of R, resulting in a stress of 4.06. Control samples are shown in black and NEC and
non-NEC deaths are shown in red for those included in Cluster I or green for those samples included in Cluster II. Clusters of samples with similar
microbial composition were systematically identified using the Ward minimum variance method. These clusters are labeled using roman
numerals I through IV. All NEC cases were found in either Cluster I or Cluster II only. The samples from the two non-NEC deaths are also found in
Cluster I. (B) Bars indicate the relative abundance of the ten most common genera in samples from individual infants, whose study numbers are
noted on the horizontal axis. Samples are grouped according to case or control status and the cluster in which they were identified. NEC:
necrotizing enterocolitis; NMDS: non-metric dimensional scaling.
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Enterobacteriaceae, P = 0.010). All six NEC-II/Cluster A in-
fants versus 8 (42%) of 19 control samples were composed
of 90% or more Proteobacteria (P = 0.020). We systematic-
ally compared the composition of samples, and found, as inthe prior week, that during days 10 to 16, NEC-I samples
had a significantly higher relative abundance of Firmicutes
than NEC-II samples, specifically, Bacilli (median 33%,
NEC-I versus 0.3%, NEC-II, P = 0.020). However, the rela-
tive abundances of these taxa in NEC-I cases during days
Figure 4 NMDS ordination of microbial communities for days 10 to 16 of life. (A) This ordination was based on weighted UniFrac beta
diversity and run with three dimensions in the vegan package of R, resulting in a stress of 2.43. Controls are shown in black and NEC and
non-NEC deaths in either red (cases identified as NEC-I in the ordination for days 4 to 9) or green (cases identified as NEC-II in the ordination for
days 4 to 9). Clusters identified using the Ward minimum variance method are indicated in this ordination as A, B and D; C is identified as an
outlier value. (B) Bars indicate the relative abundance of the ten most common genera in samples from individual infants, whose study numbers
are noted on the horizontal axis. NEC sub-types (NEC-I and NEC-II) correspond to the NEC cases included in Cluster I and Cluster II, respectively, in
the ordination of samples for days 4 to 9 (Figure 3). The clusters identified in this ordination are indicated by column headers. Clusters indicate
microbial community similarity. NEC: necrotizing enterocolitis; NMDS: non-metric dimensional scaling.
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extreme as that observed earlier (median ≥98% Firmicutes
or Bacilli during days 4 to 9). In contrast, NEC-II cases
became even more dominated by Proteobacteria, specific-
ally, the Enterobacteriaceae (median 99.6%, NEC-II versus
38%, NEC-I, P = 0.020). Furthermore, during days 10 to
16, NEC-II samples also had a significantly greater relative
abundance of Proteobacteria compared to all controls
(median 99.6%, NEC-II versus 84%, controls, P = 0.01).
In summary, four NEC cases were classified as NEC-I,
all of whom were in Cluster I, uniquely characterized by ≥
98% relative abundance of Firmicutes, class Bacilli, during
postnatal days 4 to 9. Six NEC cases were classified as
NEC-II, all of whom were in Cluster A during days 10 to
16 as well as Cluster II during days 4 to 9. These NEC-II
cases were all composed of ≥90% Proteobacteria, family
Enterobacteriaceae, in samples from postnatal days 10 to
16. One NEC infant (subject 16) lacked a sample from days
10 to 16 and could not be formally classified, but followed
the pattern of NEC-II based on their sample for days 4 to 9,
which was dominated by Escherichia and is within Cluster
II. All three non-NEC deaths were characterized by early
Firmicutes dysbiosis, as for NEC-I. One of these non-NEC
deaths (subject 40) lacked a sample from days 4 to 9, but
was considered to be a high Firmicutes dysbiosis based on
their sample for days 10 to 16, which was predominantly
composed of Staphylococcus. The primary ordinations of
beta diversity (Figures 3 and 4) included all samples and all
non-rare sequence reads, but ordination using rarefied
samples (Additional file 2: Figure S1) was also conducted
and had the same pattern as that shown in Figures 3 and 4.
The alpha diversity of the microbial communities was
then reanalyzed in relation to these NEC sub-types, as
before using the full set of OTUs without eliminating rare
sequence reads but rarefying samples to 2,000 sequence
reads per sample. No significant differences were found in
NEC sub-types by either the Simpson or Chao1 indices.
We then compared the clinical characteristics of the NEC-I
and NEC-II infants. NEC-I onset occurred between postna-
tal days 7 and 21, while NEC-II onset occurred between
postnatal days 19 and 39 (P = 0.086, Kruskal–Wallis test).
It is noteworthy that the non-NEC deaths, which clustered
with NEC-I samples in the ordination of samples from days
4 to 9, had a similarly high Firmicutes dysbiosis in the first
week of life, and that these deaths occurred between days 9
to 17, the same postnatal period during which NEC-I cases
occurred. We then compared the two NEC sub-types in
relation to each variable listed in Table 1, as shown in
Additional file 2: Table S1. The only statistical difference in
the two NEC sub-types was in the administration of antibi-
otics to the mother at the time of delivery. No NEC-I
infants, but 6 (86%) of the 7 NEC-II infants, were born of
mothers who were given antibiotics at the time of delivery
(P = 0.015). While different delivery modes did not readilyexplain the association between NEC-II and maternal anti-
biotic use, we examined the beta diversity of the microbial
communities in relation to delivery mode and NEC or con-
trol status, and observed a tendency for NEC-I to cluster
with C-section delivery, and NEC-II to cluster with vaginal
delivery (Additional file 2: Figure S2). For two other clinical
factors, patent ductus arteriosus (PDA, a heart problem of
preterm infants, which has been linked to later-onset NEC)
and primiparity, we observed a trend (P = 0.089) towards a
different distribution in NEC-I and NEC-II cases.
Each factor was independently found in only 1 (25%)
of 4 NEC-I infants versus 6 (86%) of 7 NEC-II infants. No
other clinical characteristics appeared to differ between
the NEC sub-types, nor in comparison to controls.
DNA extraction
As DNA extraction methods can affect the results of stud-
ies of the 16S rRNA gene, we undertook a series of analyses
to identify potential effects in our data. Examination of the
extraction protocol in relation to beta diversity found
no influence on identification of community clusters
(Additional file 2: Figure S3A). Examination of the
extraction protocol in relation to the relative abundance of
bacteria at all taxonomic levels found taxa that differed by
extraction method, but none of the taxa identified also
differed significantly between NEC or NEC sub-types and
controls (Additional file 2: Figure S3B). Finally, examin-
ation of the extraction protocol in relation to alpha diver-
sity found no association with the Simpson index, but did
find association with the Chao1 index (P = 0.01). Finally,
we examined the extraction protocol in regression models
of alpha diversity in relation to NEC, and found that it did
not influence the findings. These data strengthen our
conclusion that early differences occur in the microbiome
of premature infants prior to onset of NEC, independent
of extraction techniques.
Urinary metabolomic analysis
Principal component analysis did not demonstrate any quali-
tative clustering in the set of urinary metabolites in relation
to all NEC cases, NEC-I or NEC-II versus controls, nor the
NEC sub-types in relation to each other. Individual urinary
metabolite values were compared using t-tests corrected for
multiple comparisons. No urinary metabolites differed sig-
nificantly among all NEC cases and controls. However,
three metabolites, alanine, pyridoxine (4-pyridoxate) and
histidine, significantly distinguished NEC-I and NEC-II
from each other as well as one of the NEC sub-types
from controls (Figure 5 and Additional file 2: Table S2).
Alanine was significantly (P < 0.001) higher in NEC-I ver-
sus NEC-II and NEC-I versus the control samples though
the metabolite did not differ between all NEC versus con-
trol samples (Figure 5A). Pyridoxine followed a pattern
similar to alanine, though not as significant. The
Figure 5 Box plots of urinary alanine and histidine in relation
to NEC sub-types versus controls. Urine samples collected during
days 4 to 9, restricted to one sample per infant (31 samples).
Analysis of urinary alanine, pyridoxine and histidine among NEC-I,
NEC-II, death and control subjects using multiple samples per
individual (60 samples) is shown in Supplementary Information,
Table S2 of Additional file 2. (A) Urinary alanine. Using the Kruskal–
Wallis test, urinary alanine was significantly higher in NEC-I vs
controls (P = 0.044) and NEC-I than NEC-II (P = 0.023), but did not
differ between NEC-II vs controls or all NEC vs controls. (B) Urinary
histidine. Using the Kruskal–Wallis test, urinary histidine was
significantly lower in NEC-II vs controls (P = 0.023). Histidine also
tended to be lower in NEC-II vs NEC-I (P = 0.059), but did not differ
between NEC-I vs controls or all NEC vs controls. (C) Ratio of urinary
alanine to histidine. Using the Kruskal–Wallis test, the ratio of urinary
alanine to histidine was significantly higher in NEC cases overall vs
controls (P = 0.023), but did not differ between the NEC sub-types.
The optimal cut-point in the alanine:histidine ratio to differentiate
NEC cases from controls was identified as a ratio greater than 4
(predictive value 78%, P = 0.007). NEC: necrotizing enterocolitis.
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pattern and was significantly lower in NEC-II samples
than controls (P = 0.01) and NEC-I samples (P < 0.001).
Alanine, pyridoxine and histidine are commonly syn-
thesized by bacterial enzymes, as documented by KEGG
[56] and may be considered plausible biomarkers of bacter-
ial dysbiosis. We analyzed the relationship of these urinary
metabolites to microbial community characteristics in our
dataset, using only the first collected urine sample within
the window for days 4 to 9 when multiple samples were
available. Alanine (Table 2) was significantly associated with
characteristics of the intestinal microbial community.
Alanine levels were most strongly associated (P < 0.001)
with Cluster I samples identified in the ordination for days
4 to 9, including the NEC-I cases, non-NEC deaths and the
controls in that cluster. Alanine was also directly correlated
with the relative abundance of Firmicutes (P = 0.009),
and inversely correlated with the relative abundance
of both Proteobacteria (P = 0.027) and Propionibacterium
(P = 0.015). Alanine was not associated with the number of
days elapsed between collection of the urine sample and
case onset, and thus appeared to be associated with
dysbiosis rather than the host response. Pyridoxine was not
as strongly associated with microbial community charac-
teristics, and its association was explained by correlation
with alanine (data not shown). Histidine was not independ-
ently associated with microbial community characteristics
(Table 2), but had a strong inverse association with the
number of days between collection of the urine sample
and case onset (Spearman’s rho = −0.71, P = 0.004). Thus,
histidine appeared to be associated with the host response
rather than dysbiosis. Because alanine and histidine were
observed to have distinct and possibly complementary
associations in relation to NEC-I and NEC-II (Table 2 and
Figure 5), we examined the ratio of alanine to histidine in
relation to NEC outcomes (Figure 5C) and dysbiosis
(Table 2). Remarkably, the ratio was positively associated
with overall NEC (Kruskal–Wallis, P = 0.001), was inversely
associated with the relative abundance of Propionibacterium
(Spearman’s rho = −0.57, P = 0.002), and did not differ by
NEC sub-type nor in relation to time between sample
collection and disease onset.
Predictive biomarkers
To systematically evaluate the signatures identified above as
potential predictors of NEC onset, we analyzed the area
under the receiver operating curve (ROC), beginning with
defined microbial colonization characteristics (Table 3).
First, we examined high Firmicutes dysbiosis (≥98% relative
abundance in samples from days 4 to 9), which occurred in
4 of 9 NEC cases versus 0 of 18 controls (P = 0.007) who
had a sample during days 4 to 9. This measure had a good
predictive value (72%) and optimal specificity (100%), but
very poor sensitivity (44%). Next, we examined the absence
Table 2 Association between urinary metabolite values, microbial community characteristics and NECa
Characteristic Alanine Histidine Alanine:
histidine ratio
Spearman’s rho (P value)
Firmicutes, relative abundance +0.49 +0.32 +0.20
(P = 0.009) (P = 0.095) (P = 0.315)
Proteobacteria, relative abundance −0.42 −0.24 −0.16
(P = 0.027) (P = 0.221) (P = 0.413)
Propionibacterium, relative abundance −0.45 +0.02 −0.57
(P = 0.015) (P = 0.920) (P = 0.002)
Median values by cluster or NEC status (Kruskal–Wallis P value)
Cluster I samples versus 3.34 0.59 4.97
All other samples 1.52 0.44 3.46
(P < 0.001) (P = 0.140) (P = 0.029)
Cluster II samples versus 1.52 0.44 3.51
All other samples 2.46 0.59 4.86
(P = 0.007) (P = 0.104) (P = 0.403)
NEC samples versus 2.13 0.33 6.32
All others excluding non-NEC deaths 1.72 0.53 3.42
(P = 0.467) (P = 0.169) (P = 0.022)
NEC-I versus 2.81 0.55 4.86
All others excluding non-NEC deaths 1.57 0.44 3.51
(P = 0.023) (P = 0.394) (P = 0.177)
NEC-II versus 1.50 0.25 7.35
All others excluding non-NEC deaths 1.84 0.53 3.53
(P = 0.229) (P = 0.015) (P = 0.126)
aThe urine and stool samples were collected from 28 infants between postnatal days 4 to 9. Analyses include 9 NEC cases, 2 deaths and 17 controls, except
analysis of NEC, NEC-I and NEC-II, for which the non-NEC deaths were removed as a competing cause. Metabolites measured as normalized peak intensity.
Significant values are bolded.
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potential predictor, which occurred with all NEC cases but
only 44% of 18 controls (P = 0.009). While the predictive
value of the absence of Propionibacterium was good (78%)
for prediction of NEC, with optimal sensitivity (100%), the
specificity was poor (56%). We then examined high
Proteobacteria dysbiosis in days 10 to 16 samples as a
predictor of subsequent NEC. ROC analysis identified two
cut-points for high Proteobacteria dysbiosis, ≥ 90% or ≥98%Table 3 Microbial and metabolite predictors of NEC
Criteria Description
1 High Firmicutes dysbiosis (≥98%, days 4 to 9) 4
2 No Propionibacterium (days 4 to 9) 9/
3 High Proteobacteria dysbiosis (≥90%, days 10 to 16) 6
4 Dysbiosis (criterion 1 or 3) 7/
5 Combined criteria 2 and 4 (no Propionibacterium + dysbiosis) 7/
6 Urinary alanine:histidine ratio >4 (days 4 to 9) 9/
aP values based on Fisher’s exact test. The variations in denominator are due to varrelative abundance, both of which maximized the predictive
value (62%), but neither was significant. We selected the ≥
90% cut-point, as it included all NEC-II cases identified in
Cluster II/Cluster A by ordination. We then examined the
likelihood of developing NEC from having either form of
dysbiosis. This analysis, limited to infants with samples in
both time periods, found that all 7 NEC cases versus 8
(50%) of 16 controls (P = 0.052) had a form of early
dysbiosis, which increased the predictive value to 75%. But,NEC Controls Pa Predictive
value (c)
Sensitivity Specificity
/9 (44%) 0/18 (0) 0.007 72% 44% 100%
9 (100%) 8/18 (44%) 0.009 78% 100% 56%
/9 (67%) 8/19 (42%) 0.420 62% 67% 58%
7 (100%) 8/16 (50%) 0.052 75% 100% 50%
7 (100%) 4/16 (25%) 0.001 88% 100% 75%
11 (82%) 5/20 (25%) 0.007 78% 82% 75%
ying sample availability.
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a combination of either form of dysbiosis and lack of
Propionibacterium, which occurred in 7 of 7 NEC cases
and 4 (25%) of 16 controls (P = 0.001), and thus, had ideal
sensitivity (100%) and good specificity (75%).
We then examined urinary metabolites as surrogate
markers for prediction of NEC. On their own, alanine, pyri-
doxine and histidine were not significantly associated with
a risk of overall NEC. However, when analyzed together,
alanine and histidine were significantly associated with
NEC (Figure 5C and Table 2). ROC analysis found the
optimal cut-point to be a urinary alanine:histidine ratio >4
(Table 3), which yielded a predictive value of 78%. Alanine:
histidine ratio values above the cut-point occurred in 9
(82%) of 11 NEC cases and 5 (25%) of 20 controls
(P = 0.007), providing very good sensitivity (82%)
and good specificity (75%).
In summary, the predictive values of variables defining
aspects of the early intestinal microbiome or urinary
metabolome ranged from 62% to 88%. Each potentially
predictive biomarker that we examined was significant
except for Proteobacteria dysbiosis, which had the lowest
predictive value (62%). Proteobacteria dysbiosis was sig-
nificant as a predictive variable only if examined together
with Firmicutes dysbiosis (75% predictive value). The
highest predictive value, 88%, obtained from the combin-
ation of either form of dysbiosis and the absence of Propi-
onibacterium in the first week of life, suggests the upper
limit of prediction that may be obtained from analysis of
the early microbial community composition. Given the
small sample size, validation is necessary in larger studies
as well as other populations. Nevertheless, these data pro-
vide strong initial proof of concept that early microbial
colonization has a critical role in the development of
NEC. This perspective is reinforced by finding a urinary
marker (alanine:histidine ratio >4) from analysis of
samples from the first week of life, which was associ-
ated with microbial community composition and had
a predictive value of 78% for prediction of NEC.
Discussion
Intestinal colonization has long been thought to contribute
to NEC in preterm infants, despite a failure to consistently
identify a single pathogen or pathogenic microbial commu-
nity associated with its occurrence. The results of this study
indicate the need to focus metagenomic research for
preterm infants on the first few weeks of life. Our study
revealed several factors that were significantly associated
with subsequent risk of NEC, specifically, the absence of
Propionibacterium in the first week and two distinct forms
of dysbiosis that occurred over the first two weeks of life:
During days 4 to 9, the microbial community prior to onset
of early NEC cases consisted predominantly (≥98%) of
Firmicutes, specifically class Bacilli, of which the dominantgenera were Staphylococcus and Enterococcus. This unique
Gram-positive microbial signature was not shared by any of
the control infants. The second clustered microbial
phenotype occurred during 10 to 16 days of life pre-
ceding later onset NEC cases, and consisted of a
Gram-negative Proteobacteria signature, specifically,
family Enterobacteriaceae, of which the dominant genera
were Enterobacter and Escherichia. The disparate timing
and composition of these high Firmicutes and high
Proteobacteria microbial signatures are intriguing, espe-
cially given their association with early versus late onset
NEC or death. We also found maternal antepartum anti-
biotic use to be significantly higher in NEC-II compared to
NEC-I cases. While there appeared to be a trend towards
association of NEC-I with more C-section delivery and
NEC-II with more vaginal delivery, this was not significant.
Our data also suggested a trend towards lower alpha diver-
sity of samples from later NEC cases compared to controls,
but this was also not statistically significant. However, the
limited sample size of this study does not preclude the
possible differences that might be identified from analysis
of larger studies of the early microbiome in future.
While we are not aware of any previous study that has
demonstrated two distinct forms of intestinal dysbiosis
prior to onset of NEC, previous studies support the plausi-
bility of our findings. Consistent with our finding that dis-
tinct forms of dysbiosis were composed of Firmicutes and
Proteobacteria, Koenig et al. [51] reported that these phyla
are strongly negatively correlated with each other in normal
infant colonization. A previous study of 18 preterm infants
by Mai et al. [10] reported that the relative abundance of
Firmicutes was higher in samples taken one week prior to
NEC onset compared to controls, followed by higher abun-
dance of Proteobacteria within 72 hours prior to NEC
onset. Although the authors did not describe distinct forms
of dysbiosis for distinct subgroups as reported here, their
findings nevertheless suggested a key role for both major
phyla at distinct timings. Finally, Taur et al. reported two
forms of dysbiosis following antibiotic administration in
allogeneic hematopoietic transplant patients; consistent
with our study, one form of dysbiosis was characterized by
dominance of Firmicutes (Enterococcus and Streptococcus)
and the other form was characterized by dominance of
various Proteobacteria [57].
Our discovery of two forms of dysbiosis by metagenomic
analysis was supported by metabolomics, which identified
differences among urine samples that were collected in the
first week of life prior to case onset. These two ‘-omic’
methods provide complementary information. Urinary
metabolomics is a sensitive method of identifying groups
that differ in their intestinal bacterial colonization [25,44].
Production and utilization of specific metabolites differ
among colonizing bacteria, which in turn affects their bio-
availability to the host [26]. While metagenomic analysis of
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terial composition, metabolomic comparison of microbial
colonization phenotypes provides a snapshot of their differ-
ential metabolic activity [27-29]. In our study, three urinary
metabolites (alanine, pyridoxine and histidine) differed sig-
nificantly between one of the NEC sub-types and controls.
Urinary alanine was higher in NEC-I compared to controls,
positively correlated with the relative abundance of
Firmicutes, and negatively correlated with the relative
abundance of Proteobacteria and Propionibacterium.
Alanine is a non-essential amino acid, which is ubiquitously
incorporated into bacterial cell wall biosynthesis, a potential
target of immune sensing [58-60]. As peptidoglycan consti-
tutes most of the dry weight of Gram-positive organisms
but only a small share of the dry weight of Gram-negative
organisms, alanine seems a particularly promising candi-
date to differentiate patients whose microbiome is strongly
dominated by Gram-positive organisms. Indeed, alanine
was previously reported to be significantly elevated in the
feces of irritable bowel syndrome cases compared to
controls, and positively associated with higher intestinal
colonization with Gram-positive organisms [27]. Pyridox-
ine, also elevated in the urine of NEC-I infants versus
controls, is produced by bacteria in general [61] and may
reflect bacterial abundance or growth. But pyridoxine, a
correlate of alanine in our data, did not appear to be inde-
pendently associated with microbial community compos-
ition or NEC in the presence of alanine. A proteinogenic
amino acid, histidine, differed between NEC-II and con-
trols, but was not associated in our dataset with microbial
community composition per se. However, an in vitro study
of the metabolites of microbial growth previously reported
that histidine was lower in medium with increased growth
of Escherichia, a genus that contributed to the Proteo-
bacteria dysbiosis associated with NEC-II in our study [25].
While none of the metabolites were alone predictive of
overall NEC, the ratio of alanine to histidine was signifi-
cantly associated with NEC overall as well as with the
relative abundance of Propionibacterium.
The preterm infants in our study generally lacked micro-
biota that are known to influence healthy immune devel-
opment and oral tolerance, including Bifidobacterium,
Bacteroides fragilis and other commensal gut microflora
[23,24,62]. While the lack of these beneficial organisms is
characteristic of preterm infants, the primers used in this
study have been documented to be less than optimal for
quantitative representation of Bifidobacterium [63]. How-
ever, our own unpublished data suggest that the presence
or absence of Bifidobacterium was unlikely to have been
highly biased. In this study, we detected Bifidobacterium in
15% of the samples. From the same ongoing cohort of
preterm infants, we recently analyzed an additional 182
samples that were amplified using 515 F/806R primers and
sequenced on the MiSeq platform [41] and again found a15% Bifidobacterium detection rate. Of the additional
samples sequenced both by 515 F/806R (MiSeq) and
V3-V5 (454), the same Bifidobacterium-positive sam-
ples were identified with each method. For one
Bifidobacterium-positive sample, we generated additional
data from deep whole genome sequencing (WGS). The es-
timated relative abundances of Bifidobacterium by method
were 22% by WGS, 14% by 515 F/806R (MiSeq) and 2% by
V3-V5 (454). Taken together, these data suggest that our
use of V3-V5 primers did not significantly misrepresent the
presence or absence of Bifidobacterium colonization
in our dataset, but very likely underrepresented the
relative abundance of Bifidobacterium when present.
Propionibacterium, a genus of the phylum Actinobacteria,
was the only organism that differed significantly between
all NEC cases and controls in this study. The organism was
identified in the first postnatal week in about half of the
controls but none of later NEC cases, suggesting a potential
commensal role. This genus includes many species and
strains that are used as probiotics by the dairy industry
[54]. Other Propionibacterium commonly colonize the skin
[64] and have been reported in breast milk [65]. These
organisms are so named due to their production of
propionic acid as well as other short chain fatty acids
that have a beneficial role in intestinal health. The
role of Propionibacterium in the intestinal colonization of
infants is not known. Nevertheless, our observation sug-
gests a benefit from initial colonization with this organism,
and the possibility that other commensals may also benefit
preterm infants.
The high Firmicutes dysbiosis that we observed may
imply excessive exposure to the peptidoglycan that covers
the surface of Gram-positive organisms. TLR2 recognizes
peptidoglycan, and exhibits excessive signaling in the im-
mature enterocyte [4]. The lack of exposure to LPS-bearing
Gram-negative organisms in the first week of life may
impair the development of tolerance in preterm infants,
resulting in an even higher inflammatory response when
presented. The Proteobacteria dysbiosis that we observed
was characterized by high abundance of Enterobacteriaceae
in the second week of life, consistent with in vivo and
ex vivo studies indicating that NEC is a hyperinflammatory
state resulting from excessive TLR4 signaling in response to
LPS [9-11,13]. However, in our study, high Gram-negative
predominance occurred in both NEC and control subjects.
High relative abundance of Proteobacteria may induce
heightened vulnerability, but the development of NEC may
require additional insults or vulnerabilities, including later
exposures to pathogens or oxidative stress [66]. Alterna-
tively, control infants with similarly high colonization with
Proteobacteria may be more immunologically tolerant. Our
finding that no NEC cases but half of the controls had low
but detectable levels of Propionibacterium, and that the
presence of this organism appeared to mitigate the risk of
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second week of life, is consistent with the concept that the
early presence of commensal bacteria helps induce immune
homeostasis [23].
While early colonization might contribute in various
ways to the causal pathway leading to NEC, our findings
are consistent with the suggestion that early dysbiosis
has a time-sensitive role in dysregulation of the develop-
ing immune response [19,21]. Supporting this putative
role, a time-series analysis of the intestinal transcripts of
gnotobiotic and conventionalized mice demonstrated
that immune genes respond to microbial colonization in
a temporal sequence that coordinates the development
of the immune system to achieve homeostasis [20]. For
example, T-cell maturation and tolerance-associated
functions, such as IL-10 and Foxp3, are significantly
increased in conventionalized mice by day eight after
introduction of microbiota, a timing relevant to our
findings. However, our study does not address causality.
Experimental studies are needed of microbial host inter-
actions and immune development of the immature
mucosa to understand the potential role of time-specific
microbial dysbiosis as related to NEC in preterm infants.
The limitations of this study should also be consid-
ered. The sample size of this study was modest, and our
findings require validation in larger, multi-site cohorts.
Further, we included three non-NEC deaths as a second-
ary comparison group. The cause of death for the three
non-NEC deaths was attributed to respiratory distress
syndrome for two infants and suspected infection for one
infant. While these deaths may be considered irrelevant to
NEC, our data suggest similarity in the microbiome of
NEC and the non-NEC (non-congenital) neonatal deaths
that occurred in the same postnatal period [7,8,15]. The
reason for the observed microbial similarity between high
Firmicutes-associated NEC and non-NEC deaths in this
study is not known. None of the non-NEC deaths were
ever suspected of NEC. The infant with suspected infection
had clinical signs of infection and received antibiotics and
supportive treatment, but blood cultures were negative.
Since the pathobiology of NEC remains an enigma, and no
pathogens were identified that may have contributed to the
non-NEC deaths, we cannot explain the similarity of the
microbiome in non-NEC deaths and early NEC cases.
Nevertheless, these initial findings suggest that immune
dysregulation secondary to dysbiosis may be common to
NEC and some non-NEC deaths.
Conclusions
Our findings provide important new insights, particularly
regarding the role of the early microbiome in subsequent
risk of NEC, including early Gram-positive and Gram-
negative forms of dysbiosis. Further, the timing of onset of
NEC tended to differ by the form of dysbiosis. While olderpreterm infants tend to have earlier onset of NEC [3],
neither infant gestational age nor birth weight explain our
findings. All study infants were <29 weeks gestation and <
1,200 g birth weight, and neither variable differed between
NEC and control infants nor between NEC cases with a mi-
crobial phenotype characterized as Firmicutes (Bacilli) or
Proteobacteria (Enterobacteriaceae) dysbiosis. We speculate
that our findings may be relevant for understanding the
variation in timing of NEC onset that has been reported by
NICUs [3]. However, future studies are needed of
multiple, independent sites to test that hypothesis.
Regardless, the discovery of different forms of early
microbial dysbiosis provides a focus for investigation
of aberrant microbial-mucosal communication as part
of the pathobiology leading to NEC.
Our data also indicate that characterization of early
dysbiosis and the presence or absence of potentially pro-
biotic organisms, may serve as non-invasive biomarkers,
which can together predict NEC in preterm infants. Using
the combination of early microbial factors, we obtained a
very high predictive value for NEC (88%), but given the
small sample size of this study, and its conduct in a single
population, this initial estimate should be taken with
caution. Rather, the strength of this study is that it
provides proof of concept that clinically significant
prediction of NEC may be achieved by directly measuring
fecal samples, or indirectly through surrogate biomarkers
such as urinary metabolites during the first weeks of life.
Further characterization of NEC, and potential sub-types of
NEC, through –omic approaches and clinical and immuno-
logic assessments of early postnatal life is needed to
advance understanding of this complex disease.Data availability
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